Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The Poliovirus Type 1 capsid protein refers to the structural proteins (VP1, VP2, VP3, VP4) that form the outer shell (capsid) of poliovirus serotype 1. The capsid protects the viral RNA genome and mediates host cell entry by interacting with the PVR (CD155) receptor. These proteins are crucial for viral infectivity and are the primary targets of neutralizing antibodies induced by polio vaccines.
Vaccines induce neutralizing antibodies against capsid proteins, preventing viral attachment and entry into host cells.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Poliovirus Type 1 Capsid Protein.